Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) drew a synopsis of meaningful financial and research achievements in its annual report for the fiscal year 2023 ending Aug. 31, culminating in an agreement to be acquired by Exopharm Limited, an Australian Securities Exchange-listed company. Throughout 2023, the biotechnology company, which focuses on …

Legal marijuana sales in Connecticut set a new record in November, with nearly $25.7 million in total sales for the month. That figure includes $15.4 million in sales to adult consumers—the highest amount since the […]

Vancouver-based psychedelics firm Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) secured $4.3 million in financing with which to continue operations, the company announced Wednesday, with an option to obtain an additional $11.1 million. The funding was delivered by Helena Global Investment Opportunities 1 Ltd. through a securities purchase agreement …

The Daily Hit is a recap of the top financial news stories for Dec. 5, 2023. On the Site Curaleaf to Sell Vermont Assets for Undisclosed Amount Zenbarn Farms plans to acquire Vermont Patients Alliance and all Vermont assets currently operated by Curaleaf. VPA was one of the original medical …